BioMarin accuses engineer of stealing 1,800 files

BioMarin Pharmaceuticals has accused a former engineer who went to work for competitor Sangamo Therapeutics of stealing more than 1,800 files containing confidential information and trade secrets.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

J&J unit accuses rival of ‘shocking’ trade secrets theft

11 February 2021 A Johnson & Johnson unit has accused eye care product manufacturer Alcon of trade secrets theft, alleging that it had perpetrated “piracy of a nearly unfathomable scale” in ripping off a computer code.

Big Pharma

Sihuan sues equity group over Botox trade secrets

30 September 2021 A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.

Generics

BioMarin, MSD sue Aurobindo over rare disease drug

26 April 2022 BioMarin Pharmaceutical and MSD, have sued Aurobindo Pharmaceuticals for patent infringement in a dispute over the drug Kuvan, used to treat a rare genetic disorder.

More on this story

Americas

J&J unit accuses rival of ‘shocking’ trade secrets theft

Big Pharma

Sihuan sues equity group over Botox trade secrets

30 September 2021 A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.

Generics

BioMarin, MSD sue Aurobindo over rare disease drug

26 April 2022 BioMarin Pharmaceutical and MSD, have sued Aurobindo Pharmaceuticals for patent infringement in a dispute over the drug Kuvan, used to treat a rare genetic disorder.

More on this story

Americas

J&J unit accuses rival of ‘shocking’ trade secrets theft

Big Pharma

Sihuan sues equity group over Botox trade secrets

30 September 2021 A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.

Generics

BioMarin, MSD sue Aurobindo over rare disease drug

26 April 2022 BioMarin Pharmaceutical and MSD, have sued Aurobindo Pharmaceuticals for patent infringement in a dispute over the drug Kuvan, used to treat a rare genetic disorder.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

BioMarin accuses engineer of stealing 1,800 files

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features